Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
KenChowder's Profile
Displaying 101-150 of 1275 result(s).
CYDY CytoDyn Inc
07/01/2025 3:31:25 AM
Yes. Having a DUNS number is benefi (1)
CYDY CytoDyn Inc
06/28/2025 12:09:05 PM
(I think that many here have invest
CYDY CytoDyn Inc
06/28/2025 12:07:02 PM
Sure thing. Misiu, if you think som (4)
CYDY CytoDyn Inc
06/28/2025 10:10:29 AM
There are facts that are good to p (9)
CYDY CytoDyn Inc
06/28/2025 9:42:07 AM
I agree with HH. If a person is act (5)
CYDY CytoDyn Inc
06/26/2025 4:57:47 PM
Well, for starters, we shouldn't n (9)
CYDY CytoDyn Inc
06/26/2025 5:10:12 AM
It will not be to difficult to show (5)
CYDY CytoDyn Inc
06/26/2025 5:04:46 AM
Ganesha, apparently it is an option (19)
CYDY CytoDyn Inc
06/26/2025 2:41:48 AM
The dosage: Five mCRC patients rece (7)
CYDY CytoDyn Inc
06/25/2025 6:06:39 PM
Increased mOs from 7.5 months to 15 (7)
CYDY CytoDyn Inc
06/24/2025 1:59:53 AM
Abstract is released tomorrow at 6: (8)
CYDY CytoDyn Inc
06/19/2025 12:38:54 PM
Thanks, Enjay. I don't know, what d (3)
CYDY CytoDyn Inc
06/19/2025 7:52:50 AM
Mr3, I believe the lowest dosage wa (7)
CYDY CytoDyn Inc
06/19/2025 7:06:24 AM
The CRC ESMO poster will be present (8)
CYDY CytoDyn Inc
06/17/2025 10:58:34 AM
Oh for God's sake. When he says 202 (11)
CYDY CytoDyn Inc
06/17/2025 9:04:51 AM
Don't know what you mean here. Sorr
CYDY CytoDyn Inc
06/17/2025 7:00:02 AM
Thank fortune this is a board for (12)
CYDY CytoDyn Inc
06/16/2025 3:37:51 PM
No, that's exactly what he didn't s (19)
CYDY CytoDyn Inc
06/16/2025 3:14:21 PM
"Market raise"? Dr. Jay has said th (5)
CYDY CytoDyn Inc
06/14/2025 11:39:27 AM
I know that Gilead's drug had no in
CYDY CytoDyn Inc
06/11/2025 12:57:52 PM
Yes, but the results for two other (3)
CYDY CytoDyn Inc
06/11/2025 11:48:40 AM
Results for four Leron trials submi (12)
CYDY CytoDyn Inc
06/11/2025 7:12:52 AM
As Shakespeare would say, "Somethin (5)
CYDY CytoDyn Inc
06/11/2025 3:17:30 AM
The FDA HIV BLA response letter fro (11)
CYDY CytoDyn Inc
06/10/2025 6:00:04 PM
Basket trial also 30: "This is a si (3)
CYDY CytoDyn Inc
06/10/2025 10:55:22 AM
I agree with this. Zsmith's great s (8)
CYDY CytoDyn Inc
06/10/2025 10:03:00 AM
Very helpful, Brentie. Compare the (5)
CYDY CytoDyn Inc
06/10/2025 8:44:48 AM
My69 wrote, "KC, ... 3 pooled trial (1)
CYDY CytoDyn Inc
06/10/2025 6:09:51 AM
Many thanks, My. That is pretty ama (9)
CYDY CytoDyn Inc
06/10/2025 3:41:53 AM
My, can you provide a link so we ca (7)
CYDY CytoDyn Inc
06/04/2025 5:36:43 PM
Read Ohm's post earlier today on ho (1)
CYDY CytoDyn Inc
06/04/2025 3:37:03 PM
Atezolizumab was withdrawn from bre (9)
CYDY CytoDyn Inc
06/04/2025 9:03:25 AM
So Tecentriq was discontinued in 20 (14)
CYDY CytoDyn Inc
06/02/2025 1:30:36 PM
I think it is pretty good. He doesn (4)
CYDY CytoDyn Inc
06/02/2025 10:43:20 AM
Never mind Chat. ESMO was a breast (4)
CYDY CytoDyn Inc
06/02/2025 2:20:56 AM
Not sure what this one has to do wi (1)
CYDY CytoDyn Inc
06/02/2025 2:14:49 AM
So the abstract appeared in Februar (1)
CYDY CytoDyn Inc
06/01/2025 3:18:35 PM
Article from February 2025, I belie (4)
CYDY CytoDyn Inc
05/31/2025 6:43:24 AM
Debu Tripathy is the new Scientific (25)
CYDY CytoDyn Inc
05/30/2025 11:21:53 AM
The DSMB can then recommend restric (3)
CYDY CytoDyn Inc
05/30/2025 3:23:59 AM
Usually around halfway through a tr (9)
CYDY CytoDyn Inc
05/28/2025 1:25:06 PM
Article in Benzinga re CYDY, "A Pen (11)
CYDY CytoDyn Inc
05/27/2025 11:58:06 AM
Agree. I've wondered if you could i (8)
CYDY CytoDyn Inc
05/27/2025 10:06:36 AM
Hey, that's a great question! Yes, (5)
CYDY CytoDyn Inc
05/27/2025 7:03:10 AM
No, it's hasn't been trialed on hum (5)
CYDY CytoDyn Inc
05/27/2025 2:35:45 AM
Is Leronlimab ready for human trial (12)
CYDY CytoDyn Inc
05/24/2025 12:09:39 PM
It absolutely is a stunning result. (11)
CYDY CytoDyn Inc
05/23/2025 10:27:22 AM
We discussed this when the Barca co (3)
CYDY CytoDyn Inc
05/22/2025 3:06:05 PM
Not sure what the date was of my fi (22)
CYDY CytoDyn Inc
05/22/2025 9:26:06 AM
That AI response doesn't mention PD (2)
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • Raytech Holding Limited Implements Share Consolidation Plan
  • Marex Group Investors: Important Class Action Update
  • Meta's AI Transformation Under Zuckerberg: A Bright Future Ahead
  • Cryptocurrency Markets React to Fed Chair Powell's Comments
  • LG Energy Solution's Impressive Q3 2025 Performance Highlights
  • Securities Class Action Filed Against Wildermuth Fund and Auditor
  • Fluor Corporation Shareholder Update: Class Action Lawsuit Insights
  • KBR Investors Face Class Action: Critical Deadline Approaching
  • James Hardie Investors Alert: Key Deadline Approaches Fast
  • Cytokinetics Facing Class Action - Key Information for Investors
  • Molina Healthcare Investors: Important Legal Updates and Guidance
  • TeraWulf Inc. Boosts and Prices $900 Million Convertible Notes
  • Investors Alert: Class Action Lawsuit Against WPP plc Overview
  • LG Energy Solution's Q3 2025 Financial Highlights Unveiled
  • Vista Expands XO Services in Asia to Meet Aviation Demand
  • Hollyland Empowers Young Creators with Sound Campus Initiative
  • TeraWulf Secures $900 Million for Growth Through Notes Offering
  • New Virtual Program Aims to Solve Car Seat Installation Issues
  • Jamie Dimon on Office Culture: Young Employees at Risk
  • Enhancing Sino-Korean Literary Ties Through Cultural Exchanges
  • Cohen Veterans Network Marks 5 Years of Service Expansion in Hawaii
  • Athabasca Oil Corporation's Thriving Q3 2025 Financial Snapshot
  • Athabasca Oil's Q3 2025 Report: Solid Growth Amid Market Challenges
  • Universal Music Group Partners with Udio for AI Music Innovation
  • Elevating Patient Care: Freedom Surgical Center's New Partnership
  • IQAX and CargoNPay Innovate with AI in Shipping Solutions
  • Ubiqconn Technology Showcases Innovations at Global Conference
  • Innovative Heart Valve Solutions Revealed at Leading Conference
  • ArkBio Advances Monoclonal Antibody Study to Combat RSV
  • Global Expansion of Chinese E-commerce During Singles Day
  • Biltmore's Enchanted Christmas Celebrations Through History
  • Celebrate the Magic of the Holidays at Biltmore Estate
  • Rubicon Organics Set to Share Q3 2025 Financial Results Soon
  • Envista Holdings Posts Impressive Q3 2025 Earnings Results
  • Innovative Partnership Between Universal Music and Udio Unveiled
  • Celebrating Talent: Latham & Watkins Promotes New Leaders
  • Energizer Holdings, Inc. Announces Upcoming Investor Webcast
  • Stride, Inc. Faces Scrutiny as Allegations Emerge
  • Rubicon Organics Unveils Q3 2025 Financial Results Details
  • Baxter International, Inc. Investors Encouraged to Act Now
  • Exploring ASC36: A Breakthrough in Obesity Treatment
  • Canton Fair Showcases Agricultural Innovations and Safety
  • Canton Fair Showcases Innovation in Agriculture Sustainability
  • Transforming Building Materials with Threekit AI Solutions
  • Ascentage Pharma's Upcoming Investor Engagements in November
  • Ascentage Pharma's Strategic Participation in Investor Events
  • Motiva's Dynamic Q3 2025 Financial Performance Revealed
  • Dynamix Corporation III Set to Launch $175 Million IPO Soon
  • National Healthcare Properties Set to Reveal Q3 Results Soon
  • How $1,000 Invested in AMD Has Grown Over 5 Years
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site